MS
ROIV icon

Maven Securities’s Roivant Sciences ROIV Stock Holding History

Maven Securities’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,000
Closed -$887K – 958
2024
Q4 		$887K Sell
75,000
-325,000
-81% -$3.84M 0.02% 446
2024
Q3 		$4.62M Buy
+400,000
New +$4.55M 0.09% 196
2024
Q2 		– Sell
-30,000
Closed -$316K – 992
2024
Q1 		$316K Buy
+30,000
New +$323K 0.02% 268
2023
Q3 		– Sell
-200,000
Closed -$2.02M – 1216
2023
Q2 		$2.02M Sell
200,000
-50,000
-20% -$447K 0.03% 295
2023
Q1 		$1.84M Buy
+250,000
New +$2.06M 0.04% 316

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Maven Securities's ROIV Position: Q1 2025 in Review

Maven Securities sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 75,000 shares — an estimated $887K sold.

Maven Securities first reported a position in ROIV in Q1 2023 and held it in 5 quarters. The position peaked at $4.62M in Q3 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Maven Securities reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 75,000 Roivant Sciences shares in Q1 2025, an estimated $887K.
  • Maven Securities first reported a position in Roivant Sciences in Q1 2023 and held it in 5 quarters.
  • Maven Securities's Roivant Sciences position peaked at $4.62M in Q3 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.